Preferred Label : Myopathy, myofibrillar, 2;
Symbol : MFM2;
CISMeF acronym : MFM2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Myopathy, myofibrillar, with or without cataract and/or cardiomyopathy; Myopathy, myofibrillar, alpha-b crystallin-related; Alpha-b crystallinopathy; Myopathy, desmin-related, associated with mutation in the cryab gene;
Description : Alpha-B crystallin-related myofibrillar myopathy is an autosomal dominant muscular
disorder characterized by adult onset of progressive muscle weakness affecting both
the proximal and distal muscles and associated with respiratory insufficiency, cardiomyopathy,
and cataracts. There is phenotypic variability both within and between families (Fardeau
et al., 1978; Selcen and Engel, 2003). A homozygous founder mutation in the CRYAB
gene has been identified in Canadian aboriginal infants of Cree origin who have a
severe fatal infantile hypertonic form of myofibrillar myopathy; see 613869.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the alpha-B-crystallin gene (CRYAB, 123590.0001);
Laboratory abnormalities : Increased serum creatine kinase;
Prefixed ID : #608810;
Origin ID : 608810;
UMLS CUI : C1837317;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)